Fanconi anemia (FA) is a genetic disorder characterized by bone marrow failure, variable congenital malformations and a predisposition to malignancies. FANCB (also known as FAAP95), is the only X-linked FA gene discovered thus far. In the present study, we investigated hematopoiesis in adult Fancb deficient (Fancb −/y ) mice and found that Fancb −/y mice have decreased hematopoietic stem cell (HSC) quiescence accompanied by reduced progenitor activity in vitro and reduced repopulating capacity in vivo. Like other FA mouse models previously reported, the hematopoietic system of Fancb Fanconi anemia (FA) is a genetic disorder with at least eighteen FA complementation groups (named A through S) identified thus far [1] [2] [3] [4] . Patients with mutations in any of the 18 genes show a complex FA phenotype manifested by developmental abnormalities, bone marrow (BM) failure and cancer [5] [6] [7] [8] . Among the FA genes, FANCB, also known as FAAP95, is the only X-linked gene and can therefore be inactivated in females if the X chromosome that contains wild-type FANCB is silenced 9, 10 . It is known that human FANCB is a component of the FA core complex, crucial for FANCL stability and FANCD2 ubiquitination, a key activation step in the FA repair pathway 11, 12 . The in vivo function of FANCB is not known.
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One of the most important clinical features of FA is hematological. Children with FA often develop pancytopenia during the first few years of life [5] [6] [7] [8] . Complications of BM failure are the major causes of morbidity and mortality of FA, and approximately 80% of FA patients die from BM failure 13, 14 . To date, hematopoietic stem cell (HSC) transplantation (HSCT) is considered as the best treatment for BM failure and leukemia in FA patients [5] [6] [7] 15, 16 . Many studies indicate that FA proteins play specific roles in hematopoiesis by governing the responses of hematopoietic cells to both genotoxic and cytotoxic stresses 13, 14 . Loss of FA functions causes excessive apoptosis of HSC and progenitor cells (HSC/P) cells leading to BM failure in the early stages of FA 15, [17] [18] [19] [20] . Specifically, it has been shown that acetaldehyde-mediated DNA damage contributes to the genesis of hematopoietic failure in FA 21 . On the other hand, other studies identified an exacerbated p53/p21 DNA damage response as an important factor in the progressive impairment of hematopoeitsis in FA patients 22 . As the disease progresses, apoptosis as well as genomic instability imposes a selective pressure on FA HSC/P cells. The loss of stem cell fitness in FA HSC/P cells permits the emergence of resistant clones, which can be transformed and thereby lead to leukemia 23, 24 .
In the present study, we examined the role of FANCB in hematopoiesis using a Fancb-deficient mouse model (Fancb −/y ) recently generated in our laboratories and demonstrate that inactivation of Fancb in mice resulted in a decreased HSC pool and compromised HSC function. Furthermore, we show that the Fancb −/y mice exhibit slower hematological recovery and less tolerance to myelotoxic stress than wild-type controls. Mechanistically, we observed loss of stem cell quiescence and deregulated expression of genes involved in stem cell function and cell cycle regulation upon Fancb gene inactivation.
Results

Fancb
−/y mice exhibit normal steady-state hematopoiesis. We recently generated a Fancb mutant mouse model 25 . As Fancb is an X-linked gene 9, 10 , only male mice carrying the mutant allele (Fancb −/y ) were used for experiments (Fig. S1 ). Male Fancb −/y mice were infertile and therefore it was not possible to generate Fancb
females. This infertile phenotype associated with loss-of-function is consistent with other FA mouse models [17] [18] [19] 24, 26 . However, the genotypes of offspring from crossing Fancb +/− females with wild-type males followed predicted Mendelian frequencies, indicating that no embryonic lethality or perinatal lethality was associated with the Fancb gene mutation (data not shown).
We next examined the effect of the Fancb mutation on steady state hematopoiesis. Analysis of peripheral blood (PB) of 6-8 week-old mice showed a slight increase in white blood cell (WBC) counts in Fancb −/y mice than their male WT littermates ( Results are means ± standard deviation (SD) of three independent experiments (n = 9 per group). (B) Fancb mutation increases HSC cycling. Cells described in (A) were gated for the SLAM population and analyzed for the cell cycle using Hochest 33342/Ki67 staining. Representative plots (left) and quantification (right) are shown. Results are means ± standard deviation (SD) of three independent experiments (n = 9 per group). (C) Fancb mutation decreases HSC quiescence. BM cells from WT or Fancb −/y mice were gated for SLAM population and analyzed for BrdU incorporation. Representative plots (left) and quantification (right) are shown. Results are means ± standard deviation (SD) of three independent experiments (n = 9 per group). (D) Fancb deficiency does not increase cell apoptosis. Cells described in (A) were gated for SLAM population and analyzed for apoptosis by Annexin V and 7AAD. Representative plots (left) and quantification (right) are shown. Results are means ± standard deviation (SD) of three independent experiments (n = 9 per group). littermates. Thus, there is no indication of anemia in these mutant animals under steady state, which is consistent with other FA mouse models [17] [18] [19] 24, 26 . , we next analyzed the cell cycle profile of Fancb −/y HSCs. Hochest 33342/Ki67 staining showed that there was a significant decrease in the number of quiescent (G 0 ) and an increase in the number of cycling (S/G 2 /M) SLAM cells in Fancb −/y mice compared to WT control animals (Fig. 1B) . We also performed an in vivo BrdU incorporation assay to determine the proliferative status of HSCs in the BM. In line with the cell cycle data, the percentage of SLAM cells in S phase was significantly higher (33.98% ± 3.922 in Fancb −/y verse 22.65% ± 1.491 in WT, p = 0.0356) in Fancb −/y mice than WT animals (Fig. 1C) . However, mutation of Fancb did not affect the viability of SLAM cells at the steady state, as analyzed by Annexin V/7AAD staining (Fig. 1D) (Fig. 2B) , which is again consistent with previous reports of impaired repopulating ability of HSCs derived from other FA mouse models [29] [30] [31] . However, Fancb mutation did not alter lineage differentiation, as we observed similar percentages of donor-derived cells stained positive for CD3ε , B220 and Gr1/Mac1 in the recipients transplanted with either Fancb −/y or WT cells (Fig. 2C ). Furthermore, serial BMT transplantation confirmed a long-term repopulation defect of Fancb −/y HSCs (Fig. 2D ). In corroboration with the cell cycle data from native mice (Fig. 1B,C) , we found a significantly decreased proportion of quiescent cells in donor-derived Fancb −/y LSK cells as compared to WT donor cells (Fig. 2E ). Reduced short-and long-term engraftment suggests that Fancb deficiency may affect both stem and progenitor cells, perhaps by disrupting a competitive advantage at the early stage of engraftment. To test this notion, we performed a whole-bone-marrow (WBM) homing assay 32 , and found that Fancb deficiency decreases homing efficiency (albeit statistically not significant) of stem/progenitor-enriched (both Lin − and Lin − c-Kit + ) cells in the BM of the recipients 16 hours post-transplant (Fig. 2F ). Taken together, these results indicate a crucial role of FANCB in maintaining HSC/P function.
Reduced HSC/P frequencies in
Fancb
−/y HSC/P cells are hypersensitive to MMC. BM failure is common in FA patients but does not occur spontaneously in FA mouse models. It has been shown that the DNA cross-linker mitomycin C (MMC) can induce BM failure in Fancc −/− mice 18 . We thus examined whether MMC can also induce BM failure in Fancb −/y mice. Because the hematologic phenotype of Fancb −/y mice is similar to other FA mouse models and that FANCA mutation is most predominant among FA patients 5 , we included the Fanca −/− mice for comparison. Eight weeks after chronic exposure to a low dose of MMC (0.3 mg/kg) 18 , Fancb −/y mice showed severe pancytopenia, as evidenced by significantly decreased RBC, Hb and PLT (Fig. 3A) , and BM cellularity (Fig. 3B ). In addition, MMC induced marked reduction in LSK and SLAM cells in the BM of Fancb −/y mice, as compared to WT controls (Fig. 3C ). Similar to the Fanca −/− mice, all MMC-treated Fancb −/y mice died within three weeks due to BM failure (Fig. 3D ). These results indicate that the hematopoietic system of Fancb −/y mice is hypersensitive to the DNA cross-linking agent MMC. This is consistent with the shared MMC sensitivity of both mouse and human FA cells to MMC in vitro [5] [6] [7] [8] 18 .
−/y mice are hypersensitive to 5-FU. To further examine the impact of the loss of FANCB on stressed hematopoiesis, we injected Fancb −/y mice and their male WT littermates, along with the Fanca −/− mice as a comparative FA model, with the myeloid-ablating agent Fluorouracil (5-FU) and monitored BM recovery over a period of 30 days 28 . It is known that administration of 5-FU induces hyper-proliferation and exhaustion of HSCs 33 . We found a similar drop of the white blood cell (WBC) count at the first one week after 5-FU injection in both WT and Fancb −/y mice (Fig. 4A) . However, WBC recovery in WT mice started as early as 10 days after 5-FU treatment; whereas the recovery of WBC counts in Fancb −/y mice persistently lagged as compared to WT mice (Fig. 4A) . Of note, Fanca −/− mice showed similar lagging recovery pattern (Fig. 4A) . Concomitantly, a significantly higher fraction of SLAM cells from Fancb −/y mice were found in the S/G 2 /M phase of cell cycle (Fig. 4B ).
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Consistently, a significant increase in the number of BrdU + SLAM cell were detected in Fancb −/y mice over WT mice (63.2% ± 4.03% in Fancb −/y mice versus 39.225% ± 5.244% in WT mice; p = 0.0098) (Fig. 4C) . Consequently, 5-FU caused significantly increased mortality of Fancb −/y and Fanca −/− mice compared to WT control animals ( Fig. 4D) . Thus, like Fanca −/− mice, inactivation of Fancb renders mice hypersensitive to 5-FU-induced BM ablation, probably due to increased HSC cycling.
Fancb deficiency alters expression of genes involved in stem cell function and cell-cycle regulation. To explore the molecular mechanisms underlying the compromised HSC function observed in Fancb −/y mice, we performed RNA sequencing (RNA-seq) analysis using LSK cells isolated from Fancb −/y mice and their male WT littermates. Sequencing data were aligned using Tophat and the mm9 version of the mouse genome. Using GeneSpring GX analysis, we found 2753 unique differentially expressed genes (Fig. 5A) (Fig. 5C) . We validated the RNA-seq results by quantitative RT-PCR (qPCR) for selected genes. Consistent with our phenotypic findings (Figs 1 and 2 ), many important cell cycle control genes, such as such as Cdc25c, Ccnb1, Chek1, Ccne1, Mcm4 and Mcm2, (Fig. 5D, Upper) and Wnt/pluripotency genes, such as Wnt5a, Fzd8, Prkcb, Wnt3a, Wnt6 and Fzd5, are deregulated in Fancb −/y LSK cells (Fig. 5D, Lower) . Thus, these transcriptional changes may link dysregulation of multiple pathways to impaired HSC function in Fancb −/y . Finally, we performed rescue experiments to address whether the transcriptional dysregulation of the cell-cycle related genes in Fancb −/y LSK cells was associated with the observed increase in HSPC cycling. We chose Cdc25c and Ccnb1, both of which are critical regulators of cell entry into mitosis [34] [35] [36] , for further study. We first acutely lowered the expression of Cdc25c and Ccnb1 in LSK cells, using lentiviral shRNA. We found that reducing the level of either Cdc25c or Ccnb1 mRNA in Fancb −/y LSK cells to near WT level (Fig. 5E , Right) significantly increased (albeit not completely rescued) quiescence of the Fancb −/y LSK cells (Fig. 5E , Left), indicating that dysregulation of these two cell-cycle regulators were at least partially responsible for the decreased quiescence of Fancb -/ HSCs. To examine if knock-down of Cdc25c and Ccnb1 also rescued Fancb −/y HSC self-renewal, we performed in vitro serial replating assays using the shRNA-transduced LSK cells. The downregulation of Cdc25c or Ccnb1 in Fancb −/y LSK cells significantly increased colony numbers in first plating and, to a greater extent, in second and third platings (Fig. 5F) [17] [18] [19] 24, 26 . Consistently, our attempt to generate anemic mice by mutational disruption of the Fancb gene has not resulted in a model characteristic of the human disease. In fact, Fancb −/y mice show only minor hematological parameters characteristic of FA patients (Table 1) . Although the mechanism behind this is still lacking, possible causes are suggested by the scientific literature. For example, a recent study suggested that mice harbor longer telomere lengths than patients with FA 37 , which might protect hematopoietic cells from senescence. Alternatively, the mild phenotype in mice could be due to fewer spontaneous DNA lesions or lower levels of endogenous DNA-damaging agents, such as formaldehyde 38 or malondialdehyde 39 . Although spontaneous BM failure has not been observed in FA mice, a defect in HSC function has been observed in FA mice using competitive repopulation and serial BM transplant studies 19 , [29] [30] [31] [40] [41] [42] [43] . Indeed, we found that loss of Fancb protein compromises HSC repopulation ability and increases proportion of cycling cells in the SLAM compartment, which eventually leads to premature stem cell exhaustion (Fig. 2) . Moreover, Fancb −/y HSCs in lethally-irradiated recipients are less quiescent and are rapidly exhausted upon 5-FU challenge. This correlated with a significantly increased mortality of Fancb −/y mice (Fig. 4) . These results are also consistent with the cell cycle-related HSC defects in Fancc −/− mice reported by Li et al.
31
. It is in this context that we identify FANCB as a critical regulator that prevents HSCs from myelotoxic stress-induced cycling and excessive proliferation.
It is well-accepted that DNA repair is essential for the maintenance of hematopoietic function. In fact, mice defective in different mechanisms of genome maintenance, including homologous recombination (HR), non-homologous end joining (NHEJ), nucleotide base excision (NER), mismatch repair (MMR), DNA interstrand crosslink repair (ICL), as well as telomere maintenance, have hematopoietic stem/progenitor cell defects [44] [45] [46] [47] [48] [49] . Our data on the loss of HSC function in Fancb −/y mice further supports the importance of genome stability in maintaining the long-term repopulating capacity of HSCs. The impaired regenerative potential of the Fancb −/y bone marrow may be due to a reduced HSC reserve, functionally defective HSCs, or a combination of the two. In support of a possible role for FANCB in the pathways regulating the balance between stem cell quiescence and cell-cycle entry, our RNA-seq data identified significant difference in gene expression of several particular genes in Fancb deficient HSPCs, including those related to cell cycle control (Cdc25c, Ccnb1, Chek1, Ccne1, Mcm4, Mcm2) and HSC function (Wnt10a, Wnt16, Wnt3a, Fzd1, Fzd5, Fzd8, Prkcb) (Fig. 5) . Furthermore, our rescue experiments show that knocking down Cdc25c or Ccnb1 mRNA in Fancb −/y LSK cells to near WT level significantly increased quiescence and self-renewal capability of the Fancb −/y HSCs cells. In summary, the present study demonstrated that inactivation of Fancb in mice induces premature HSC exhaustion and identify excessive HSC cycling as one of the underlying mechanisms for the defect. These findings reveal functional interaction between the FA DNA repair pathway and cell-cycle progression in HSC maintenance. To our knowledge, this is the first study that describes X-linked hematopoietic defects associated with FA.
Methods
Mice. Generation of Fancb mutant mice has been described elsewhere 25 . Since Fancb −/y males are infertile, the female was used for mating with C57BL/6J male mice. The offspring were genotyped with the following primer sets: Fancb-WT: 5′ -AGAACCATCTGAGGATAAATGT-3′ , Fancb-F: 5′ -TTTCCAGGTCCCCGTTCTGA-3′ and Fancb-R: 5′ -CAAGAATGCGGACTGGAAA-3′ (Fig. S1) . Fanca +/+ and Fanca −/− mice were generated by interbreeding the heterozygous Fanca +/− mice 26 . 6-8 week-old BoyJ mice were used as recipients for bone marrow transplantation. All the animals, including BoyJ mice, were maintained in the animal barrier facility at the Cincinnati Children's Hospital Medical Center.
Treatments. 5-FU treatment was adapted from Kobayashi et al., 2004 28 . Briefly, a single dose (150 mg/kg) or multiple doses (135 mg/kg, weekly for 3 weeks) of 5-Fluorouracil (5-FU; Sigma-Aldrich, St. Louis, MO) was administrated intraperitoneally (i.p.) into the experimental mice. Kinetics of BM recovery or the survival of the recipients was monitored.
For in vivo mitomycin C (MMC, Sigma-Aldrich, St. Louis, MO) treatment, 6-8 week-old Fancb −/y mice or their male wild-type littermates were weekly i.p. injected with 0.3 mg/kg of MMC 18 . Blood parameters were measured 8 weeks after the injection. For acute MMC treatment, 1 mg/kg of MMC was used to determine the survival of the subjects 18 . All experimental procedures conducted in this study were approved by the Institutional Animal Care and Use Committee of Cincinnati Children's Hospital Medical Center according to approved guidelines.
BM transplantation. 1 ) were labelled with DiD dye (1:200) at 37 °C for 30 min. DiO and DiD were purchased from Vybrant Multicolor Cell-Labelling Kit (Molecular Probes, V-22889). After labelling, dyes were washed off. The DiO-labelled CD45.2 and DiD-labelled CD45.1 cells were mixed at a 1:1 ratio and transplanted into lethally irradiated (11 Gy one day before transplantation) CD45.1 recipients (2.5 × 10 6 from each donor). Sixteen hours after transplant, the recipients were euthanized and the BM was analyzed by flow cytometry for both DiO/DiD and surface lineage markers (Gr1, Mac1, B220, CD3, Ter119, from Ebioscience) and c-Kit (2B8, BD Biosciences). The ratio between the percentages of DiO + (donor) and DiD For cell cycle analysis, cells stained for surface markers were fixed and permeabilized with Cytofix/Cytoperm buffer (BD Pharmingen, San Jose, CA) followed by intensive wash using Perm/Wash Buffer (BD Pharmingen, San Jose, CA). Cells were then incubated with Hochest 33342 (Sigma-Aldrich, St. Louis, MO) and anti-mouse Ki67 antibody (BD Pharmingen, San Jose, CA) or Hochest 33342 and 150 ng/ml Pyronin Y (Sigma-Aldrich, St. Louis, MO) followed by flow cytometric analysis.
For the BrdU incorporation assay, Bromodeoxyuridine (BrdU, 150 μ l of 10 mg/ml) were intraperitoneally (i.p.) injected to subjected mice followed by BM cells isolation 14 hours later. BrdU incorporated cells (S phase) were analyzed with the APC BrdU Flow Kit (BD Biosciences, San Jose, CA), following the manufacturer's instructions. Briefly, cells were surface stained then fixed and permeabilized using BD Cytofix/Cytoperm Buffer. After 1 hour incubation with DNase at 37 °C, cells were stained with APC-conjugated anti-BrdU monoclonal antibody. 7-aminoactinomycin (7-AAD) was added to each sample right before Flow Cytometry analysis (BD Biosciences, San Jose, CA).
For cell sorting, lineage negative cells were enriched using lineage depletion columns (StemCell Technologies, Vancouver, BC, Canada) according to the manufacturer's instructions. The LSK (Lin − c-Kit + Sca-1 + ) population was acquired by using the FACSAria II sorter (BD Biosciences, San Jose, CA).
Colony-forming unit assay. LDBMCs isolated from Fancb
−/y mice or their male WT littermates were plated in a 35-mm tissue culture dish in 4 mL of semisolid medium containing 3 mL of MethoCult M3134 (Stem Cell Technologies, Vancouver, BC, Canada) and the following growth factors: 100 ng/ml SCF, 10 ng/ml IL-3, 100 ng/ml GM-CSF, and 4 units/mL erythropoietin (Peprotech, Burlington, NC). On day 7 after plating, erythroid and myeloid colonies were enumerated. For serial plating, cells from primary or secondary CFU assays were pooled and re-plated to evaluate secondary or tertiary CFUs, respectively. Hematopoietic clonal growth results were expressed as means (of triplicate plates) ± SD of three experiments.
RNA sequencing. For RNAseq analysis, RNA was extracted from LSK cells isolated from Fancb −/y mice or their male WT littermates by Trizol-type method. The RNA quality and quantity assessment, single-end sequencing and alignment of reads on mouse genome (mm9 version) were carried out in the Cincinnati Children's Hospital Medical Center Affymetrix Core using standard procedures using Illumina HiSeq2000. Bam files provided by the Core were analyzed using Genespring GX v12 (Agilent Technologies, Santa Clara, CA). Quantification of mRNA expression was done using the RefSeq database. Gene expression and fold change (FC) were evaluated between WT and Fancb −/y samples and genes with a significant difference (moderate-T test, p ≤ 0.05) and a FC ≥ 2.0 were selected to run the pathway analysis module of GeneSpring GX v12 using the curated WikiPathway database(http:// www.wikipathways.org).
Molecular cloning and materials. Hairpin sequence targeting Cdc25c (ACCTGAATCTCCGAAAGACAAA)
or Ccnb1 (CCCTCTGTAGTGAATATGTGAA) were cloned into SFLV-eGFP-shRNA vector (Dr. Lenhand Rudolph (Institute of Molecular Medicine and Max-Planck-Research, Germany) 50 . The plasmids (10 μ g each) were used to produce retroviral supernatant.
Statistics. Data were analyzed statistically using a Student's t test. Statistical measures stated in the text were based on the p values. p values < 0.05 were considered statistically significant.
